vs
艾默生(EMR)与Raymond James Financial(RJF)财务数据对比。点击上方公司名可切换其他公司
艾默生的季度营收约是Raymond James Financial的1.0倍($4.3B vs $4.2B),艾默生净利率更高(13.9% vs 13.5%,领先0.4%),艾默生同比增速更快(4.1% vs 3.5%),艾默生自由现金流更多($602.0M vs $-56.0M),过去两年Raymond James Financial的营收复合增速更高(7.1% vs -0.3%)
艾默生是总部位于美国密苏里州圣路易斯的世界500强跨国企业,业务涵盖工业自动化设备、暖通控制系统、精密测量仪器的研发制造,同时面向工业、商业、消费级市场提供工程服务及对应软件工程解决方案。
雷蒙德詹姆斯金融是美国跨国独立投资银行及金融服务机构,通过旗下子公司为个人、企业及市政主体提供多元金融服务,核心业务覆盖投资与财务规划、投资银行、资产管理等领域,总部位于美国佛罗里达州圣彼得堡。
EMR vs RJF — 直观对比
营收规模更大
EMR
是对方的1.0倍
$4.2B
营收增速更快
EMR
高出0.6%
3.5%
净利率更高
EMR
高出0.4%
13.5%
自由现金流更多
EMR
多$658.0M
$-56.0M
两年增速更快
RJF
近两年复合增速
-0.3%
损益表 — Q1 FY2026 vs Q1 FY2026
| 指标 | ||
|---|---|---|
| 营收 | $4.3B | $4.2B |
| 净利润 | $605.0M | $563.0M |
| 毛利率 | 53.2% | — |
| 营业利润率 | 17.8% | — |
| 净利率 | 13.9% | 13.5% |
| 营收同比 | 4.1% | 3.5% |
| 净利润同比 | 3.4% | -6.2% |
| 每股收益(稀释后) | $1.07 | $2.79 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
EMR
RJF
| Q4 25 | $4.3B | $4.2B | ||
| Q3 25 | $4.9B | $4.2B | ||
| Q2 25 | $4.6B | $3.8B | ||
| Q1 25 | $4.4B | $3.8B | ||
| Q4 24 | $4.2B | $4.0B | ||
| Q3 24 | $4.6B | $4.0B | ||
| Q2 24 | $4.4B | $3.8B | ||
| Q1 24 | $4.4B | $3.6B |
净利润
EMR
RJF
| Q4 25 | $605.0M | $563.0M | ||
| Q3 25 | $637.0M | $604.0M | ||
| Q2 25 | $586.0M | $436.0M | ||
| Q1 25 | $485.0M | $495.0M | ||
| Q4 24 | $585.0M | $600.0M | ||
| Q3 24 | $996.0M | $602.0M | ||
| Q2 24 | $329.0M | $492.0M | ||
| Q1 24 | $501.0M | $476.0M |
毛利率
EMR
RJF
| Q4 25 | 53.2% | — | ||
| Q3 25 | 51.9% | — | ||
| Q2 25 | 52.6% | — | ||
| Q1 25 | 53.5% | — | ||
| Q4 24 | 53.5% | — | ||
| Q3 24 | 51.3% | — | ||
| Q2 24 | 52.8% | — | ||
| Q1 24 | 52.2% | — |
营业利润率
EMR
RJF
| Q4 25 | 17.8% | — | ||
| Q3 25 | 16.4% | — | ||
| Q2 25 | 16.1% | 14.7% | ||
| Q1 25 | 14.2% | 17.5% | ||
| Q4 24 | 18.6% | 18.6% | ||
| Q3 24 | 14.7% | — | ||
| Q2 24 | 10.4% | 17.1% | ||
| Q1 24 | 16.2% | 16.7% |
净利率
EMR
RJF
| Q4 25 | 13.9% | 13.5% | ||
| Q3 25 | 13.1% | 14.4% | ||
| Q2 25 | 12.9% | 11.3% | ||
| Q1 25 | 10.9% | 12.9% | ||
| Q4 24 | 14.0% | 14.9% | ||
| Q3 24 | 21.6% | 15.0% | ||
| Q2 24 | 7.5% | 13.1% | ||
| Q1 24 | 11.4% | 13.1% |
每股收益(稀释后)
EMR
RJF
| Q4 25 | $1.07 | $2.79 | ||
| Q3 25 | $1.12 | $2.96 | ||
| Q2 25 | $1.04 | $2.12 | ||
| Q1 25 | $0.86 | $2.36 | ||
| Q4 24 | $1.02 | $2.86 | ||
| Q3 24 | $1.74 | $2.85 | ||
| Q2 24 | $0.57 | $2.31 | ||
| Q1 24 | $0.87 | $2.22 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | — | $9.9B |
| 总债务越低越好 | $7.6B | — |
| 股东权益账面价值 | $20.3B | $12.6B |
| 总资产 | $41.9B | $88.8B |
| 负债/权益比越低杠杆越低 | 0.37× | — |
8季度趋势,按日历期对齐
现金及短期投资
EMR
RJF
| Q4 25 | — | $9.9B | ||
| Q3 25 | — | $11.4B | ||
| Q2 25 | — | $9.2B | ||
| Q1 25 | — | $9.7B | ||
| Q4 24 | — | $10.0B | ||
| Q3 24 | — | $11.0B | ||
| Q2 24 | — | $9.1B | ||
| Q1 24 | — | $10.0B |
总债务
EMR
RJF
| Q4 25 | $7.6B | — | ||
| Q3 25 | $8.9B | — | ||
| Q2 25 | $8.3B | — | ||
| Q1 25 | $8.2B | — | ||
| Q4 24 | $6.6B | — | ||
| Q3 24 | $7.7B | — | ||
| Q2 24 | $7.1B | — | ||
| Q1 24 | $7.6B | — |
股东权益
EMR
RJF
| Q4 25 | $20.3B | $12.6B | ||
| Q3 25 | $20.3B | $12.5B | ||
| Q2 25 | $19.9B | $12.3B | ||
| Q1 25 | $19.2B | $12.2B | ||
| Q4 24 | $20.5B | $11.9B | ||
| Q3 24 | $21.6B | $11.7B | ||
| Q2 24 | $20.8B | $11.2B | ||
| Q1 24 | $20.9B | $11.0B |
总资产
EMR
RJF
| Q4 25 | $41.9B | $88.8B | ||
| Q3 25 | $42.0B | $88.2B | ||
| Q2 25 | $42.5B | $84.8B | ||
| Q1 25 | $42.0B | $83.1B | ||
| Q4 24 | $42.6B | $82.3B | ||
| Q3 24 | $44.2B | $83.0B | ||
| Q2 24 | $45.6B | $80.6B | ||
| Q1 24 | $46.4B | $81.2B |
负债/权益比
EMR
RJF
| Q4 25 | 0.37× | — | ||
| Q3 25 | 0.44× | — | ||
| Q2 25 | 0.42× | — | ||
| Q1 25 | 0.42× | — | ||
| Q4 24 | 0.32× | — | ||
| Q3 24 | 0.36× | — | ||
| Q2 24 | 0.34× | — | ||
| Q1 24 | 0.36× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $699.0M | $-10.0M |
| 自由现金流经营现金流 - 资本支出 | $602.0M | $-56.0M |
| 自由现金流率自由现金流/营收 | 13.9% | -1.3% |
| 资本支出强度资本支出/营收 | 2.2% | 1.1% |
| 现金转化率经营现金流/净利润 | 1.16× | -0.02× |
| 过去12个月自由现金流最近4个季度 | $4.4B | $1.4B |
8季度趋势,按日历期对齐
经营现金流
EMR
RJF
| Q4 25 | $699.0M | $-10.0M | ||
| Q3 25 | $3.1B | $796.0M | ||
| Q2 25 | $1.1B | $691.0M | ||
| Q1 25 | $241.0M | $117.0M | ||
| Q4 24 | $777.0M | $830.0M | ||
| Q3 24 | $3.3B | $510.0M | ||
| Q2 24 | $1.1B | $711.0M | ||
| Q1 24 | $743.0M | $391.0M |
自由现金流
EMR
RJF
| Q4 25 | $602.0M | $-56.0M | ||
| Q3 25 | $2.7B | $752.0M | ||
| Q2 25 | $977.0M | $634.0M | ||
| Q1 25 | $154.0M | $71.0M | ||
| Q4 24 | $694.0M | $789.0M | ||
| Q3 24 | $2.9B | $460.0M | ||
| Q2 24 | $998.0M | $655.0M | ||
| Q1 24 | $661.0M | $342.0M |
自由现金流率
EMR
RJF
| Q4 25 | 13.9% | -1.3% | ||
| Q3 25 | 54.9% | 17.9% | ||
| Q2 25 | 21.5% | 16.5% | ||
| Q1 25 | 3.5% | 1.8% | ||
| Q4 24 | 16.6% | 19.6% | ||
| Q3 24 | 63.1% | 11.5% | ||
| Q2 24 | 22.8% | 17.4% | ||
| Q1 24 | 15.1% | 9.4% |
资本支出强度
EMR
RJF
| Q4 25 | 2.2% | 1.1% | ||
| Q3 25 | 8.9% | 1.1% | ||
| Q2 25 | 2.0% | 1.5% | ||
| Q1 25 | 2.0% | 1.2% | ||
| Q4 24 | 2.0% | 1.0% | ||
| Q3 24 | 9.1% | 1.2% | ||
| Q2 24 | 2.1% | 1.5% | ||
| Q1 24 | 1.9% | 1.3% |
现金转化率
EMR
RJF
| Q4 25 | 1.16× | -0.02× | ||
| Q3 25 | 4.86× | 1.32× | ||
| Q2 25 | 1.83× | 1.58× | ||
| Q1 25 | 0.50× | 0.24× | ||
| Q4 24 | 1.33× | 1.38× | ||
| Q3 24 | 3.35× | 0.85× | ||
| Q2 24 | 3.31× | 1.45× | ||
| Q1 24 | 1.48× | 0.82× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
EMR
| Other | $1.8B | 41% |
| Software And Systems | $1.0B | 24% |
| Intelligent Devices | $996.0M | 23% |
| Safety And Productivity | $503.0M | 12% |
RJF
暂无分部数据